Ledger.Open graph →
SEC Form D · filed April 4, 2025

NEURONA THERAPEUTICS, INC

Offering
$101.7M
Sold
$101.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Peter Svennilson · South San Francisco, CADirectorMicah Kinsler · Suite 101, AZDirectorLeo R. Guthart · South San Francisco, CADirectorJohnathan L. Manning · Savannah, GAExecPeter Svennilson · Encinitas, CADirectorMoshe Lifschitz · Englewood, NJDirectorTim Kutzkey · South San Francisco, CADirectorRay Kelleher · South San Francisco, CADirectorMichael Burwell · New York, NYDirectorCatherine Sohn · South San Francisco, CADirectorCory Nicholas · South San Francisco, CAExec · Director · PromoterAlger A. St-Jean · Toronto, Ontario, CanadaDirectorRay Kelleher · South San Francisco, CADirectorMinyoung Sohn · Denver, COExec · Director · PromoterBrad Margus · South San Francisco, CADirectorDhivya Venkat · London, United KingdomDirectorErica Whittaker · South San Francisco, CADirectorAlan Badey · New York, NYExec · Director · PromoterJames Stutz · South San Francisco, CAExecBobby Ocampo · Solana Beach, CADirectorWilliam R. Woo · New York, NYDirectorJames Stutz · South San Francisco, CAExecJeffrey F. O'Donnell Sr · Malvern, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗